Læknablaðið : fylgirit - 01.06.2009, Blaðsíða 6

2 7 T H CONGR SCAND ASSOC UROL
F Y L G I R I T 6 1
13:30-13:50 13:50-14:10 Chronic pelvic pain in men, clinical update: Hans Hedilin, Sweden Chronic pelvic pain in women, clinical update: Ýr Logadóttir, lceland/Sweden
14:10-16:34 SESSION I - Free papers 5+3 min Chair: Rafn Hilmarsson, lceland/Sweden, and Ola Bratt, Sweden
14:10 01 Initial management of prostate cancer: First year experience of extended registration within the Norwegian National Prostate Cancer Registry (NoPCR) E Hernes, E Hem, A Kyrdalen, R Kvále, O Klepp, K Axcrona, SD Fossá
14:18 02 Tumour negative prostate biopsies prior to later cancer diagnosis and radical prostatectomy C Gade, MM Mortensen, M Borre
14:26 03 Perineal biopsies of the prostate in patients with previous negative biopsies M Dimmen, K Axcrona, B Brennhovd
14:34 04 Extended pelvic lymphadenectomy for prostate cancer: Results and complications C Lindberg, M Annerstedt, S Gudjonsson, R Hilmarsson, O Bratt
14:42 05 Robot-assisted pelvic lymph node dissection in prostate cancer W Soller, T Jiborn, G Ahlgren, P Elfving, A Bjartell
14:50 06 Outcome following open versus robot-assisted laparoscopic radical prostatectomy M Borre
15:00-15:30 Coffee break and poster viewing
15:30 07 Will robotic radical prostatectomy really do better than retropubic radical prostatectomy regarding morbidity? AD Seyer-Hansen, S Skou, M Borre, T Lynnerup, KV Pedersen
15:38 08 Mortality rate after retropubic radical prostatectomy HO Beisland, E Servoll, L Vlatkovic, T Sæter, G Waaler
15:46 09 Tertiary Gleason pattern is a predictor of PSA-relapse after radical prostatectomy E Servoll, L Vlatkovic, T Sæter, G Waaler, HO Beisland
15:54 10 The oncological outcome and preoperative prediction of pT3 prostate cancer patients M Mortensen, B Ulhoi, M Borre
16:02 11 Decreased seeds migration with Mick-applicated Loose 1251-seeds in prostate brachytherapy M Hojgaard, AA Jassem, N Norgaard, K Andersen, KJ Mikines
16:10 12 A phase III study of endocrine treatment with or without radiotherapy in locally advanced or high-risk localized prostate cancer SD Fossá on behalf of participants in SPCG-7/SFUO-3
16:18 13 The CASODEX EPC program - 10 years of follow-up P Iversen, D McLeod, M Wirth, W See, T Morris
16:26 14 Efficacy and safety of degarelix vs. leuprolide in a 12-month, randomised, phase III study P Iversen, TK Olesen, B-E Persson
16:34-16:39 Break - 5 min
16:39-17:35 SESSION II - Free papers 5+3 min Chair: Börje Lungberg, Sweden, and Baldvin Kristjánsson, lceland
16:39 15 PVP with 120W Greenlight laser in the treatment of patients with BPH on anticoagulants G Piotrowicz, H Zielinski, R Jedynak
16:47 16 Plasma button electrode vaporization of the prostate - short term outcome and complications M Hojgaard, L Fahrenkrug, J Schou
16:55 17 Development of UTI after TURP; Indwelling urinary catheters as risk factors M Cek, P Tenke, K Naber, KV Pedersen, TEB Johansen on behalf of the GPIU*-investigators and the board of ESIU
17:03 18 Hypoxia-inducible factor-1a mRNA and protein levels in renal cell carcinoma A Lidgren, A Bergh, K Grankvist, G Lindh, B Ljungberg
17:11 19 Is laparoscopic-assisted cryablation for renai cancer safe and nefronsparing? L Lund, M Jonler, LJ Petersen, J Abrahamsen
17:19 20 Early pulmonary metastases in renal cell carcinoma. - Prevalence and operability SJ Oddsson, S Hardarson, V Petursdottir, E Jonsson, H Vidarsdottir, GV Einarsson, T Gudbjartsson
17:27 21 Incidental detection of renal cell carcinoma is an independent prognostic marker - Results of a long term whole population study HB Palsdottir, S Hardarson, V Petursdottir, A Jonsson, E Jonsson, GV Einarsson, T Gudbjartsson
6 LÆKNAblaðið 2009/95